The Latest Cardiac and Vascular News
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease.
New site highlights clinical evidence and streamlined access to the Vivio® System for outpatient HF diagnosis PASADENA, Calif., May 7, 2026 /PRNewswire/ — Ventric Health, maker of the Vivio® System, the only FDA-cleared non-invasive device for measuring elevated left ventricular…
MILFORD, Mass.–(BUSINESS WIRE)–FASTR Pilot Study Published in JACC: HF
NEW YORK–(BUSINESS WIRE)– #Cardiology–AccurKardia, an innovator in ECG-based diagnostics technology, today announced that AK+ Guard™ has been selected as winner of the “Best New ECG Technology Solution” award in the 10th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies and products in the global digital health and medical technology market. AI-powered AK+ Guard hyperkale
SAN FRANCISCO–(BUSINESS WIRE)–Elation Health, the clinical-first technology platform for modern primary care success, today announced it has licensed the American Heart Association PREVENTTM risk calculator to be embedded within Clinical Insights, its AI-powered clinical decision support tool within its EHR platform. The American Heart Association and American College of Cardiology (ACC) along with nine other medical colleges released updated cholesterol and lipid management guidelines making
MAASTRICHT, Netherlands & YOKNEAM, Israel–(BUSINESS WIRE)– #DMVO–Rapid Medical reports DISTALS trial results showing the safety and efficacy of TIGERTRIEVER 13 in distal ischemic stroke, with encouraging outcomes.
SANTA ROSA, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the appointment of Steve Deitsch to its Board of Directors. Mr. Deitsch brings more than 25 years of global leadership experience across medtech and the broader healthcare sector. He currently serves as Chief Executive Officer of Caristo Diagnostics, a global leader in AI technology for
Prominent cardiologist and digital health leader joins Eko Health to advance clinical innovation and global impact of AI-enabled cardiac detection SAN FRANCISCO, May 7, 2026 /PRNewswire/ — Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and…
DALLAS, TX, UNITED STATES, May 5, 2026 /EINPresswire.com/ — Solaris Endovascular, Inc, a medical device company focused on next-generation endovascular therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its first-in-class Solaris DE™ drug-eluting covered stent indicated for use in hemodialysis patients for […]
— Coils minimize CT/MRI artifacts, remain radiopaque under fluoroscopy — BOULDER, Colo., May 6, 2026 /PRNewswire/ — Embolization, Inc., will present its novel vascular embolization device, using proprietary shape-memory biocompatible polymers, at the Annual GEST Conference, Booth No….
